Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/15/23
End: 09/15/25
Due: 09/15/26
Phase: N/A
Priority: Normal
Start: 02/28/22
End: 01/31/25
Due: 01/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 1 Study of AWT020 in Advanced Cancer | NCT06092580 | Anwita Biosciences | user2@example.com | None | 2023-09-15 | 2025-09-15 | 2026-09-15 | - | - | 2025-07-14 |
| Phase 1 First-in-human Study of JS014 | NCT05296772 | Anwita Biosciences | user2@example.com | None | 2022-02-28 | 2025-01-31 | 2026-01-31 | - | - | 2025-07-14 |